Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2019

Open Access 01-12-2019 | Breast Cancer | Primary research

H/ACA box small nucleolar RNA 7B acts as an oncogene and a potential prognostic biomarker in breast cancer

Authors: Yihan Sun, Endong Chen, Yuefeng Li, Danrong Ye, Yefeng Cai, Qingxuan Wang, Quan Li, Xiaohua Zhang

Published in: Cancer Cell International | Issue 1/2019

Login to get access

Abstract

Background

Breast cancer (BC) is the most frequent malignancy occurring in women worldwide. Emerging evidence indicates that small nucleolar RNAs (snoRNAs) play a role in tumor development. In the current study, we evaluated expression profiles and functions of snoRNAs associated with BC.

Methods

We analyzed the expression levels of snoRNAs between breast cancer and normal tissues in TCGA database and found that SNORA7B is upregulated in BC. We confirmed this result in clinical cancer tissues and BC cell lines via qRT-PCR. Then, we investigated clinical significance in public datasets and biological function of SNORA7B using a series of in vitro gain- and loss-of-function experiments.

Results

SNORA7B expression was significantly upregulated in samples from patients with BC in both public database and our clinical tissues compared to its expression in normal tissues. Meanwhile, patients with high SNORA7B expression have worse prognosis. Inhibition of SNORA7B expression impaired cell growth, proliferation, migration, and invasion via inducing apoptosis.

Conclusions

SNORA7B functions as an important oncogenic snoRNA in BC and may serve as a potential prognosis biomarker for BC.
Appendix
Available only for authorised users
Literature
1.
Siegel RL, Miller KD, PhD AJD. Cancer statistics, 2018. Cancer J Clin. 2018;68(1):271.CrossRef
2.
Hutchinson L. Breast cancer: challenges, controversies, breakthroughs. Nat Rev Clin Oncol. 2010;7(12):669–70.PubMedCrossRef
3.
Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P. Breast cancer statistics and markers. J Cancer Res Ther. 2014;10(3):506.PubMed
4.
Ribelles N, Perez-Villa L, Jerez JM, Pajares B, Vicioso L, Jimenez B, De LV, Franco L, Gallego E, Marquez A. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index. Breast Cancer Res. 2013;15(5):R98.PubMedPubMedCentralCrossRef
5.
Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst. 2008;100(16):1179–83.PubMedPubMedCentralCrossRef
6.
Martens-Uzunova ES, Olvedy M, Jenster G. Beyond microRNA–novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer Lett. 2013;340(2):201–11.PubMedCrossRef
7.
Henras AK, Dez C, Henry Y. RNA structure and function in C/D and H/ACA s (no)RNPs. Curr Opin Struct Biol. 2004;14(3):335–43.PubMedCrossRef
8.
Hamma T, Ferré-D’Amaré AR. The box H/ACA ribonucleoprotein complex: interplay of RNA and protein structures in post-transcriptional RNA modification. J Biol Chem. 2010;285(2):805–9.PubMedCrossRef
9.
Accardo MC, Giordano E, Riccardo S, Digilio FA, Iazzetti G, Calogero RA, Furia M. A computational search for box C/D snoRNA genes in the Drosophila melanogaster genome. Bioinformatics. 2004;2004:3293–301.CrossRef
10.
Mcmahon M, Contreras A, Ruggero D. Small RNAs with big implications: new insights into H/ACA snoRNA function and their role in human disease. Wiley Interdiscip Rev RNA. 2015;6(2):173.PubMedCrossRef
11.
Murray JL, Sheng J, Rubin DH. A role for H/ACA and C/D small nucleolar RNAs in viral replication. Mol Biotechnol. 2014;56(5):429–37.PubMedCrossRef
12.
Sahoo T, Gaudio DD, German JR, Shinawi M, Peters SU, Person RE, Garnica A, Cheung SW, Beaudet AL. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008;40(6):719–21.PubMedPubMedCentralCrossRef
13.
Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, Listenberger LL, Behlke MA, Ory DS, Schaffer JE. Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab. 2011;14(1):33–44.PubMedPubMedCentralCrossRef
14.
15.
Chang LS, Lin SY, Lieu AS, Wu TL. Differential expression of human 5S snoRNA genes. Biochem Biophys Res Commun. 2002;299(2):196–200.PubMedCrossRef
16.
17.
Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W, Petros J, Li Q, Vessella RL, Kibel AS. SnoRNA U50 is a candidate tumor suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet. 2008;17(7):1031.PubMedPubMedCentralCrossRef
18.
Mei Y, Liao J, Shen J, Yu L, Liu B, Liu L, Li R, Ji L, Dorsey SG, Jiang Z. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 2012;31(22):2794–804.PubMedCrossRef
19.
Okugawa Y, Toiyama Y, Toden S, Mitoma H, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Gut. 2017;66(1):107–17.PubMedCrossRef
20.
Su H, Xu T, Ganapathy S, Shadfan M, Long M, Huang TH, Thompson I, Yuan ZM. Elevated snoRNA biogenesis is essential in breast cancer. Oncogene. 2014;33(11):1348–58.PubMedCrossRef
21.
Yin QF, Hu SB, Xu YF, Yang L, Carmichael GG, Chen LL. SnoVectors for nuclear expression of RNA. Nucleic Acids Res. 2015;43(1):e5.PubMedCrossRef
22.
Toffanonioche C, Gautheret D, Leclerc F. Revisiting the structure/function relationships of H/ACA (-like) RNAs: a unified model for Euryarchaea and Crenarchaea. Nucleic Acids Res. 2015;43(16):7744.CrossRef
23.
Bachellerie JP, Cavaillé J, Hüttenhofer A. The expanding snoRNA world. Biochimie. 2002;84(8):775–90.PubMedCrossRef
24.
Valleron W, Laprevotte E, Gautier EF, Quelen C, Demur C, Delabesse E, Agirre X, Prósper F, Kiss T, Brousset P. Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia. 2012;26(9):2052–60.PubMedCrossRef
25.
Liao J, Yu L, Mei Y, Guarnera M, Shen J, Li R, Liu Z, Jiang F. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer. 2010;9(1):1–10.CrossRef
26.
Popov A, Szabo A, Mandys V. Small nucleolar RNA U91 is a new internal control for accurate microRNAs quantification in pancreatic cancer. BMC Cancer. 2015;15(1):774.PubMedPubMedCentralCrossRef
27.
Zheng D, Zhang J, Ni J, Luo J, Wang J, Tang L, Zhang L, Wang L, Xu J, Su B. Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer. J Exp Clin Cancer Res. 2015;34(1):49.PubMedPubMedCentralCrossRef
28.
Crea F, Quagliata L, Michael A, Liu HH, Frumento P, Azad AA, Xue H, Pikor L, Watahiki A, Morant R. Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression. Mol Oncol. 2016;10(5):693–703.PubMedCrossRef
29.
Kiss T. Small nucleolar RNAs: an abundant group of noncoding RNAs with diverse cellular functions. Cell. 2002;109(2):145–8.PubMedCrossRef
30.
31.
Dieci G, Preti M, Montanini B. Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics. 2009;94(2):83–8.PubMedCrossRef
32.
Zhang Y, Xu C, Gu D, Wu M, Yan B, Xu Z, Wang Y, Liu H. H/ACA box small nucleolar RNA 7A promotes the self-renewal of human umbilical cord mesenchymal stem cells. Stem Cells. 2016;35(1):222.PubMedCrossRef
33.
Pekarsky Y, Rynditch A, Wieser R, Fonatsch C, Gardiner K. Activation of a novel gene in 3q21 and identification of intergenic fusion transcripts with ecotropic viral insertion site I in leukemia. Can Res. 1997;57(18):3914–9.
34.
Lahortiga I, Vázquez I, Agirre X, Larrayoz MJ, Vizmanos JL, Gozzetti A, Calasanz MJ, MDO. Molecular heterogeneity in AML/MDS patients with 3q21q26 rearrangements. Genes Chromosom Cancer. 2004;40(3):179–89.PubMedCrossRef
35.
Kemp Z, Carvajal-Carmona L, Spain S, Barclay E, Gorman M, Martin L, Jaeger E, Brooks N, Bishop DT, Thomas H. Evidence for a colorectal cancer susceptibility locus on chromosome 3q21–q24 from a high-density SNP genome-wide linkage scan. Hum Mol Genet. 2006;15(19):2903–10.PubMedCrossRef
36.
Winqvist R, Virkkunen P, Grzeschik KH, Vihko P. Chromosomal localization to 3q21—qter and two TaqI RFLPs of the human prostate-specific acid phosphatase gene (ACPP). Cytogenet Genome Res. 1989;52(1–2):68–71.CrossRef
37.
Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, Van SR, Wolman SR. High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat. 2006;96(2):177–86.PubMedCrossRef
38.
Richard F, Pacynagengelbach M, Schlüns K, Fleige B, Winzer KJ, Szymas J, Dietel M, Petersen I, Schwendel A. Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer. 2000;89(3):305–10.PubMedCrossRef
39.
Allred DC, Clark GM, Elledge R, Fuqua SA, Chamness GC, Osborne CK, Mcguire WL. Elevated levels of mutant p53 protein are associated with high proliferation rates and poor clinical outcome in node-negative breast cancer. Can J Oncol. 1992;3:6–13.
40.
Matera AG, Terns RM, Terns MP. Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol. 2007;8(3):209–20.PubMedCrossRef
Metadata
Title
H/ACA box small nucleolar RNA 7B acts as an oncogene and a potential prognostic biomarker in breast cancer
Authors
Yihan Sun
Endong Chen
Yuefeng Li
Danrong Ye
Yefeng Cai
Qingxuan Wang
Quan Li
Xiaohua Zhang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2019
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-019-0830-1

Other articles of this Issue 1/2019

Cancer Cell International 1/2019 Go to the issue

Hypothesis

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4

Primary research

Multivariate analysis of clinicopathological and prognostic significance of miRNA 106b~25 cluster in gastric cancer

Primary research

miR-450b-5p loss mediated KIF26B activation promoted hepatocellular carcinoma progression by activating PI3K/AKT pathway

Primary research

Identification of a 6-gene signature predicting prognosis for colorectal cancer

Primary research

Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway

Primary research

Identification of differentially expressed circRNAs and a novel hsa_circ_0000144 that promote tumor growth in gastric cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits